Antiviral drug ‘may have clinical benefit’ on COVID-19, study says
Doctors caution that results of uncontrolled trial are far from proof of effectiveness
By 
THE EXPERIMENTAL ANTIVIRAL drug remdesivir showed potential promise in a small study among severely ill coronavirus patients, raising hopes that it might prove to be an effective treatment for COVID-19. But the study results are far from conclusive proof, and doctors warned patients and health care providers against false hopes of a sudden treatment breakthrough.(...)